Skip to search formSkip to main contentSkip to account menu

dimethoxycurcumin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Dimethoxycurcumin (DiMC) is a synthetic analog of curcumin with superior inter‐related pro‐oxidant and anti‐cancer activity, and… 
2015
2015
Dimethoxycurcumin (DMC) is an analog of curcumin with superior efficacy in various disease models. Currently, drug delivery… 
Highly Cited
2014
Highly Cited
2014
Although curcumin suppresses the growth of a variety of cancer cells, its poor absorption and low systemic bioavailability have… 
2014
2014
PurposeCurcumin is an ideal chemopreventive and antitumor agent characterized by poor bioavailability and low stability. The… 
Review
2011
Review
2011
Abstract Dimethoxycurcumin (Dimc), a metabolically stable analogue of curcumin, is under investigation as an anti-tumour agent… 
2011
2011
Dimethoxycurcumin (Dimc), a synthetic analogue of curcumin, that has been reported to exhibit better in vivo stability and anti… 
2010
2010
Purpose Curcumin (Cur) has been reported to induce apoptosis in human renal carcinoma Caki cells. Dimethoxycurcumin (DMC), one of… 
Highly Cited
2009
Highly Cited
2009
  • S. JeongG. Oh H. Pae
  • Journal of clinical biochemistry and nutrition
  • 2009
  • Corpus ID: 768032
Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione] induces heme oxygenase-1 (HO-1) expression via activation… 
Highly Cited
2008
Highly Cited
2008
Excess production of nitric oxide (NO) by inducible NO synthase (iNOS) in activated macrophages is linked to acute and chronic… 
Highly Cited
2007
Highly Cited
2007
Purpose: The plant-derived compound curcumin has shown promising abilities as a cancer chemoprevention and chemotherapy agent in…